Loading…
Back To Schedule
Tuesday, June 16 • 11:30am - 12:30pm
#223 L: Next Generation Analytics: Harnessing the Power of Nonclinical SEND Datasets to Improve Success in Early Clinical Development

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-20-663-L04-P; CME 1.00; IACET 1.00; RN 1.00

The nonclinical SEND data standard represents a tremendous opportunity to enable large-scale data analytic approaches for nonclinical data, but further harmonization of SEND compliant data is necessary. The panel discussion will discuss both the opportunity represented by SEND, the further harmonization needed to realize this opportunity, and potential solutions to address the current gaps in data harmonization.

Learning Objectives

Recognize the opportunity that SEND compliant datasets represent to enable the implementation of large-scale, robust analytic approaches to assess pre-clinical data; Identify the current challenges of performing cross-study analysis using SEND compliant nonclinical data; Discuss solutions that will address the challenges with cross-study analysis to enable large-scale analytics.

Chair

Todd Page, PhD

Speaker

Novel Opportunities and Technical Challenges Utilizing SEND Compliant Nonclinical Data
Kevin Snyder, PhD

Cross-Study Analysis: Lessons Learnied From Collaboration
Todd Page, PhD

Panelist
Susan DeHaven, MSc

Panelist
Debra Oetzman



Speakers
TP

Todd Page

Director, Toxicology, Eli Lilly and Company
Dr. Page received a doctorate degree in pharmacology from the University of Nebraska Medical Center. He then completed a postdoctoral fellowship at the University of Wisconsin-Madison studying immunotoxicology. He is currently a Director of Toxicology at Eli Lilly and Company. In... Read More →
avatar for Susan DeHaven

Susan DeHaven

Director, Data Standards and Business Applications, Sanofi
DO

Debra Oetzman

Senior Information Scientist, Data Standards Lead, Instem LSS Ltd.
avatar for Kevin Snyder

Kevin Snyder

Pharmacologist, CDER/OND, FDA


Tuesday June 16, 2020 11:30am - 12:30pm EDT
TBD Virtual Event Horsham, PA 19044
  06: PreClin Dev-EarlyPhaseCR, Forum